Patient of Monroe Carell Jr. Children's Hospital at Vanderbilt First in World to Receive New Investigational Gene Editing Therapy
Jul 12, 2021 at 04:28 pm by Staff
A 9-year-old patient of Monroe Carell Jr. Children's Hospital at Vanderbilt is the first in the world to receive an investigational gene editing therapy for Methylmalonic Acid.... Read More